← Evidence map

ArticleResearch and practice in thrombosis and haemostasis2023

Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis.

Steven W Pipe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36908770